CD8A and melanoma: Tumor-infiltrating lymphocytes such as CD+8 in patients with melanoma are inversely related to sentinel lymph node positivity and directly correlated with a statistically significant improvement in both melanoma-specific survival time and with the recurrence-free of disease [24].